Hepatic Failure due to Hepatitis B Reactivation in a Patient with Ulcerative Colitis Treated with Prednisone
We would like to emphasize to consider a HBV reactivation after discontinuation of a prednisone therapy and report a patient with HBV-infection who developed HBV reactivation following corticoid treatment of ulcerative colitis. Paracentesis showed spontaneous bacterial peritonitis. The patient was transferred to our tertiary care center due to severe liver failure with hepatic encephalopathy (Grade 3) and coagulopathy (Factor V 7%, PT 10%, aPTT 88 sec). We immediately started a therapy with lamivudine and listed the patient for superurgent liver transplantation, which could be performed 24hours latter. One day after transplantation the patient presented with primary graft non function, which required immediate re-transplantation. After re-transplantation the patient recovered quickly. To prevent HBV re-infection, we initiated a long-term prophylaxis with anti-HBs immunoglobulins in combination with lamivudine. Three and a half years after re-transplantation there is no evidence for HBV reinfection and the patients has fully recovered.
This case highlights the importance of HBV screening in IBD patients requiring an immunosuppressive therapy such as corticosteroids, methotrexate, azathioprine or new biological agents such as anti-TNF agents. 5, 6 In our opinion, HBV carriers with IBD requiring such a treatment should also be treated prophylactically with a nucleoside or nucleotide analogues approved for the treatment of HBV infection.
